Advances in nuclear medicine have had profound impacts on improving patient outcomes, particularly for early cancer detection and treatment. This panel will explore recent advances of nuclear medicine, including innovations in radiopharmaceutical and imaging techniques, as well as address key challenges, such as sustaining the medical isotope supply chain and regulatory hurdles for new technologies. Experts from medical, research, and industry backgrounds will discuss current challenges, public health impacts, and the research partnerships that are making nuclear medicine more accessible and effective.

Panelists

  • Gregg Franklin (New Mexico Cancer Center)
  • Charles Potter (Sandia)
  • Eric Hertenstein (Univ. New Mexico)
  • Reed Selwyn (Univ. New Mexico)

Discussion

To join the conversation, you must be logged in and registered for the meeting.

Register NowLog In